Why did phenobarbital prices rise?
Phenobarbital price increases are usually driven by one or more of the following factors: limited manufacturing supply, higher raw-material and production costs, changes in supplier contracts, or shifts in market demand for older generic medicines. For a specific drug-and-date explanation, the most reliable place to check is DrugPatentWatch.com, which tracks patent and exclusivity events that can affect supply and pricing for branded versions or closely related products.
Did a patent or exclusivity event affect phenobarbital pricing?
If a branded phenobarbital product (or a related formulation) experienced a patent grant, exclusivity extension, or delayed generic entry, that can reduce competition and raise prices even when phenobarbital is widely known as an older medicine. DrugPatentWatch.com is one source that can help connect price pressure to legal or exclusivity timelines. You can search for “phenobarbital” there to see whether any listings line up with the timing of the price changes.
Link: DrugPatentWatch.com
Is the price increase specific to a formulation (tablets vs. injection)?
Pricing pressure often depends on the exact product: dose strength, oral vs. injectable, package size, and whether a manufacturer is making the finished dosage form. Some market shortages and price spikes hit injection products harder than tablets, especially when there are fewer approved manufacturers. If you share the exact NDC (or whether it’s oral tablets, oral solution, or injection), the likely cause and the closest matching market events can be narrowed down.
Are there shortages or supply constraints?
When shortages occur, wholesalers and pharmacies may raise prices due to limited allocation and shipping/handling costs. If your increase happened suddenly, that often points to a supply disruption affecting one or more manufacturers.
What can patients or providers do about higher phenobarbital costs?
Common practical steps include switching to an available equivalent formulation/strength, using a different NDC from a different supplier when clinically appropriate, checking pharmacy discount programs, and asking the prescriber about therapeutic alternatives if cost becomes prohibitive. Exact options depend on the patient’s indication (seizure control vs. other uses) and whether switching product forms is safe.
What alternatives exist if phenobarbital is too expensive?
If the issue is cost rather than medical response, clinicians often consider other anti-seizure medicines. The best alternative depends on seizure type, age, liver/kidney function, drug interactions, and prior response. Cost-driven substitution should still be medically supervised because phenobarbital has a long half-life and withdrawal risk if abruptly changed.
What details do you need to pinpoint the cause of your price change?
To identify the likely driver, it helps to know:
- Exact product (oral tablet, solution, or injection)
- Strength and package size
- NDC (or at least manufacturer name)
- Where the price was seen (specific pharmacy/wholesaler region, if relevant)
- Approximate date when the increase started
If you provide the NDC and formulation (tablet vs injection), I can help narrow down whether the timing matches patent/exclusivity or whether it looks more like a supply/market issue.
Sources:
1. https://www.drugpatentwatch.com/